Hospital General Leon
León, Guanajuato, 37320, Mexico
NCT Number: NCT02097615
At present research has generated controversy regarding the utility of antiseptics in wound management for diabetic foot ulcers syndrome. However, these studies have been done in tissues and animal models. This study involves the best presently antiseptic for residual effect and low toxicity in an approach to eliminate microorganisms promoters formation of biofilm, contributing to the treatment for accelerated closure the diabetic foot ulcers syndrome .
So it is necessary to determine if irrigation ulcer diabetic foot syndrome with chlorhexidine 0.125 % aqueous solution determines the decrease of the surface to a greater extent than the standard treatment using irrigation with sterile deionized water .
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
León, Guanajuato, 37320, Mexico
The present study be made performed at the Hospital General Leon.
Population:
People with Diabetes Mellitus state of Guanajuato.
Universe:
People with diabetes mellitus and diabetic foot syndrome Guanajuato state . sample: Will be evaluated in patients with diabetes mellitus presenting loss of continuity of the skin of the lower limbs and coming to the clinic wound´s of the León General Hospital . This clinic provides services to patients in the state of Guanajuato with diabetic foot syndrome, including them within a multidisciplinary management program .
Calculation of Sample :
72 patients; more eight for lost estimates, 40 patients for each group are required to have a 80 % chance of detecting , with a significance level of 5%, an increase in the primary outcome measure of 5% in the control group and 6 % in group experimental .
Alpha: 5 % Power : 80 %
Inclusion criteria
Indistinct gender Patients over 18 years with Diabetes Mellitus and submit ulcer from diabetic foot syndrome not involving tendon , capsule or bone.
With proper state of vascular perfusion.
Exclusion criteria
Ulcers in patients with interdigital or difficult to measure the affected surface areas.
Patients not be located at follow-up or wish to stop participating in the study.
Methodology:
Will be invited to participate in the study patients with diabetes mellitus consecutive presented with ulcers plantar to IA or IB grade classification system ulcers , University of Texas, in the area of Clinical wound´s of the Hospital General Leon between Abril and November 2014.
After explaining the study information and check which is understandable , they provide the sheet to be signed informed consent.
Subsequently selected patients will be given a vascular ultrasound to measure the ankle brachial index and determine the absence of vascular compromise.
They carry out their medical history with emphasis on analyzing clinical data , including the characteristics of the ulcer (type of exudate , measured surface area affected , type of tissue involved in the ulcer to its depth ) and biochemical parameters .
Be weighed and measured at the first visit and not having biochemical data are requested to collect this information in subsequent follow-up visit .
They were then treated with the principles of the standard treatment, under the following criteria :
Material cleaning the ulcer :
Ingredient 1: Preparation of spray application of chlorhexidine gluconate 0.125% .
Ingredient 2: Preparation of spray application of sterile deionized water .
Method of application of ingredients as described previously .
Method of randomization : is effected by assigning random numbers balanced computer, the code will be assigned to each of the ingredients which have identical presentations , they will balance to the sample size . The code will not be known by the patient, observer and analyst. Only be known by one of the advisors.
Statistical methods :
The description of the data, in the case of non-numerical variables will be performed by reporting proportions and confidence interval of 95 % (95 %) in the case of numerical variables, the description will be made based on averages and standard deviation or medians and Q1- Q3 range , depending on the result of the Kolmogorov-Smirnov test to evaluate the Gaussian distribution of the data.
Comparison of numerical variables were not performed by Chi square test . Comparison of the rates of reduction in the size of ulcers of diabetic foot syndrome for both treatments will be based on the t test for independent samples or by Kruskal- Wallis test , depending on data distribution .
In all cases be considered as the significance level alpha value <0.05 .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
chlorhexidine gluconate spray of 0.125% . Application in the area of the ulcer every 24 hours for six weeks
application every 24 hours six weeks
Time frame: 15 days
Total ulcer area shall be measured by drawing software AUTOCAD LT 2014 , which defines the edges of the ulcer surface area in each of the two photographs , to take an average of the measure and get a value to be analyzed, that value is checked against the reference area of 1 square centimeter to increase measurement accuracy .
Universidad de Guanajuato
Other
Clinical Trial of the Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water in the Closure of Diabetic Foot Ulcer Syndrome.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03643952
Bacteremia, Bacterial Infections
Nagoya, Aichi-ken, Japan
View Trial DetailsNCT01557426
Abscess, Cellulitis
Providence, Rhode Island, United States
View Trial DetailsNCT04257097
Bone Density, Bone Diseases
Bologna, Italy
View Trial DetailsNCT04286334
Bone Density, Bone Loss in Jaw
Bologna, Italy
View Trial Details